Rsv Infection clinical trials

Explore recruiting rsv infection clinical trials.

Recruiting rsv infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rsv Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety, tolerability, and efficacy of S-337395 in symptomatic nonhospitalized adults with respiratory syncytial virus who are at high risk of progression to severe disease

Bulgaria, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Immunogenicity and safety of two respiratory syncytial virus vaccine strategies in lung and allogeneic haematopoietic stem cell transplant recipients: A phase 2 trial RSVaxID

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Implementation RSV Immunization Study (IRIS)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Immunogenicity after a prime dose and revaccination with adjuvanted RSVPreF3 vaccine in the most elderly and frail population – an open-labeled phase IIIb-trial RSV Immunogenicity Study in the Elderly (RISE)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 18 Years or Above (DAN-RSV)

Denmark, Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications

Slovakia, Spain, Poland, Czechia, Netherlands, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Rsv Infection trials by city

Rsv Infection in Toronto Rsv Infection in Vancouver Rsv Infection in Montreal Rsv Infection in Calgary Rsv Infection in Edmonton Rsv Infection in Ottawa Rsv Infection in Winnipeg Rsv Infection in Quebec City Rsv Infection in Hamilton Rsv Infection in Kitchener Rsv Infection in London Rsv Infection in Halifax Rsv Infection in New York Rsv Infection in Los Angeles Rsv Infection in Chicago Rsv Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease